← FDA Drug Approvals (Drugs@FDA)

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE · Approved 2020-05-11

Drug application

FDA Application #
ANDA210765
Application type
Abbreviated New Drug Application (Generic)
Brand name
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Generic name
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Active ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Dosage form
SUSPENSION
Route
TOPICAL
Marketing status
Prescription
Sponsor
COSETTE
Manufacturer
Cosette Pharmaceuticals, Inc.
First approval
2020-05-11

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown